Case Western Reserve University

Adtalem Global Education Appoints Betty Vandenbosch to its Board of Directors

Retrieved on: 
Tuesday, January 9, 2024

Adtalem Global Education Inc. (NYSE: ATGE) recently announced the appointment of Dr. Betty Vandenbosch as an independent member of Adtalem’s board of directors, effective January 8, 2024.

Key Points: 
  • Adtalem Global Education Inc. (NYSE: ATGE) recently announced the appointment of Dr. Betty Vandenbosch as an independent member of Adtalem’s board of directors, effective January 8, 2024.
  • Vandenbosch’s many years of experience in EdTech and her expertise in innovative approaches to education make her the perfect addition to our board of directors,” said Steve Beard, Adtalem president and chief executive officer.
  • “I’m excited to join the Adtalem board of directors, especially during this pivotal period in Adtalem’s journey,” said Dr. Vandenbosch.
  • As a member of the board, Dr. Vandenbosch will advise on emerging technology and solutions that can drive student outcomes and advance innovation within the higher education space.

NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors

Retrieved on: 
Monday, January 8, 2024

Mr. Lewis has served as Chief Executive Officer of Insmed Incorporated, a global commercial-stage biopharmaceutical company, since 2012, and as Chair of Insmed’s Board of Directors since 2018.

Key Points: 
  • Mr. Lewis has served as Chief Executive Officer of Insmed Incorporated, a global commercial-stage biopharmaceutical company, since 2012, and as Chair of Insmed’s Board of Directors since 2018.
  • Mr. Lewis succeeds Sander Slootweg, Managing Partner at Forbion, who has served as Chairman of NewAmsterdam’s Board of Directors since inception.
  • I would also like to thank Sander for his support and contribution as our Chairman over the last several years.
  • I am excited to join NewAmsterdam’s Board of Directors and look forward to partnering closely with management to complete the ongoing Phase 3 program and bring obicetrapib forward.”

Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief

Retrieved on: 
Wednesday, January 3, 2024

IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in Medicine and Biology Society (EMBS) , today announced the appointment of biomedical technology veteran Mike Hess as editor-in-chief of IEEE Pulse.

Key Points: 
  • IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in Medicine and Biology Society (EMBS) , today announced the appointment of biomedical technology veteran Mike Hess as editor-in-chief of IEEE Pulse.
  • Mr. Hess is currently an adjunct professor in the Department of Biomedical Engineering at the University of Minnesota.
  • I believe that IEEE Pulse is indeed the ideal publication to fulfill this mission,” commented Metin Akay, Ph.D., IEEE EMBS Ambassador.
  • IEEE Pulse is the flagship magazine for IEEE EMBS, which reports on a broad variety of topics related to biomedical engineering.

Ohio ICU nurse builds drone agriculture business

Retrieved on: 
Friday, December 1, 2023

“They all ask, ‘Is that what I think it is?’”

Key Points: 
  • “They all ask, ‘Is that what I think it is?’”
    Yes, it’s an impressively large drone.
  • In 2022, Moore launched Lake Erie Drone, LLC, a company offering a new type of pesticide and fungicide application for local farms.
  • “What’s really cool about the drone is that it pushes the chemical into the canopy of the crop,” Moore says.
  • And he had to jump through several regulatory hurdles, involving both the Federal Aviation Association and the Ohio Department of Agriculture, to get to this point.

Femasys Inc. Announces the Appointment of James Liu, M.D., as Chief Medical Officer

Retrieved on: 
Thursday, November 30, 2023

Dr. Liu joins Femasys as the company accelerates commercialization of its product pipeline, including a new therapeutic for artificial insemination, FemaSeed®.

Key Points: 
  • Dr. Liu joins Femasys as the company accelerates commercialization of its product pipeline, including a new therapeutic for artificial insemination, FemaSeed®.
  • “With an exciting product pipeline and a culture focused on execution of the development and commercialization of differentiated women’s health procedures, Femasys stands apart in the industry,” said Dr. Liu.
  • He also served as the Division head, Reproductive Endocrinology and Infertility at the University of Cincinnati.
  • Ms. Kathy Lee-Sepsick, founder, president and chief executive officer of Femasys, commented on the appointment of Dr. Liu, stating, “It is a great pleasure to welcome Dr. James Liu to Femasys as the Company’s next chief medical officer.

Quest Diagnostics Names Yuri A. Fesko, M.D., Senior Vice President and Chief Medical Officer

Retrieved on: 
Wednesday, December 20, 2023

SECAUCUS, N.J., Dec. 20, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that Yuri A. Fesko, M.D., has been named senior vice president and chief medical officer (CMO), effective immediately.

Key Points: 
  • SECAUCUS, N.J., Dec. 20, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that Yuri A. Fesko, M.D., has been named senior vice president and chief medical officer (CMO), effective immediately.
  • Since joining Quest in 2016, Dr. Fesko has held several roles of increasing responsibility, most recently as vice president of medical affairs and senior medical director for the company's oncology services.
  • "Strong medical leadership is a critical enabler of our strategy to deliver solutions for the evolving needs of our customers, physicians, health systems and consumers," said Jim Davis, Chairman, CEO and President, Quest Diagnostics.
  • He sits on the board of directors of a joint venture of Quest Diagnostics and University of Pittsburgh Medical Center.

CyberSaint Appoints Matt Alderman as Chief Product Officer

Retrieved on: 
Monday, November 20, 2023

CyberSaint , the leader in cyber risk management, today announced the appointment of Matt Alderman as Chief Product Officer (CPO).

Key Points: 
  • CyberSaint , the leader in cyber risk management, today announced the appointment of Matt Alderman as Chief Product Officer (CPO).
  • View the full release here: https://www.businesswire.com/news/home/20231120287396/en/
    "I am thrilled to join the CyberSaint team and take on the role of Chief Product Officer," said Matt Alderman.
  • As part of this transition, CyberSaint's Founder and previous Chief Product Officer, Padraic O'Reilly, will assume the role of Founder and Chief Innovation Officer.
  • "We are delighted to welcome Matt Alderman to CyberSaint as our new Chief Product Officer," said Jerry Layden, Chief Executive Officer at CyberSaint.

Local Officials, The NRP Group, and University Hospitals, Cut Ribbon on The Davis, an Affordable Housing Community in Cleveland, Ohio

Retrieved on: 
Wednesday, November 15, 2023

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    The community is The NRP Group’s third "Health and Housing" development, conceived to address social determinants of health (SDOH).
  • This is the second of UH’s Community Wellness Centers; the first opened in Bedford, Ohio, earlier this year.
  • “We’re proud to celebrate the completion of this community, and grateful to have had an opportunity to partner with The NRP Group.
  • “The NRP Group is dedicated to creating affordable communities that provide residents with opportunities for long-term success,” said J. David Heller, President and CEO of The NRP Group.

Crownpeak Appoints Samuel Monti as Chief Executive Officer

Retrieved on: 
Tuesday, December 5, 2023

DENVER, Dec. 5, 2023 /PRNewswire/ -- Crownpeak, a leading digital experience platform (DXP), today announced the appointment of Samuel Monti as the company's Chief Executive Officer. Monti is an accomplished leader with nearly three decades of experience in finance, operations, and C-suite leadership in both public and private equity companies. At Crownpeak, Monti will further the company's successful growth, driving operational excellence and cultivating technological innovation to deliver even greater value for customers. 

Key Points: 
  • DENVER, Dec. 5, 2023 /PRNewswire/ -- Crownpeak , a leading digital experience platform (DXP), today announced the appointment of Samuel Monti as the company's Chief Executive Officer.
  • Monti is an accomplished leader with nearly three decades of experience in finance, operations, and C-suite leadership in both public and private equity companies.
  • At Crownpeak, Monti will further the company's successful growth, driving operational excellence and cultivating technological innovation to deliver even greater value for customers.
  • "This is an exciting time to be joining Crownpeak," said Samuel Monti, CEO of Crownpeak.

Crownpeak Appoints Samuel Monti as Chief Executive Officer

Retrieved on: 
Tuesday, December 5, 2023

DENVER, Dec. 5, 2023 /PRNewswire/ -- Crownpeak, a leading digital experience platform (DXP), today announced the appointment of Samuel Monti as the company's Chief Executive Officer. Monti is an accomplished leader with nearly three decades of experience in finance, operations, and C-suite leadership in both public and private equity companies. At Crownpeak, Monti will further the company's successful growth, driving operational excellence and cultivating technological innovation to deliver even greater value for customers. 

Key Points: 
  • DENVER, Dec. 5, 2023 /PRNewswire/ -- Crownpeak , a leading digital experience platform (DXP), today announced the appointment of Samuel Monti as the company's Chief Executive Officer.
  • Monti is an accomplished leader with nearly three decades of experience in finance, operations, and C-suite leadership in both public and private equity companies.
  • At Crownpeak, Monti will further the company's successful growth, driving operational excellence and cultivating technological innovation to deliver even greater value for customers.
  • "This is an exciting time to be joining Crownpeak," said Samuel Monti, CEO of Crownpeak.